Interestingly, inhibition of Chk1 has shown promising anti-cancer effects in vitro in a variety of p53 deficient human tumor cell lines through induction of caspase-3/7 dependent apoptosis, and especially sensitized colon tumors to chemotherapy in vivo [55, 56]. The gene discussed is TP53; the disease is cancer.